Epidemiology of Varicella Zoster Virus and Herpes Zoster Virus in Gulf Cooperation Council Countries: A Review of the Literature

被引:6
|
作者
Badur, Selim [1 ]
Ozudogru, Onur [2 ]
Khalaf, Mansour [3 ]
Ozturk, Serdar [1 ]
Albreiki, Sarah [4 ]
Al Awaidy, Salah [5 ]
Guzman-Holst, Adriana [6 ]
机构
[1] GSK, Istanbul, Turkey
[2] GSK, Dubai, U Arab Emirates
[3] GSK, Jeddah, Saudi Arabia
[4] King Fahd Hosp Univ, Dammam, Saudi Arabia
[5] Minist Hlth, Muscat, Oman
[6] GSK Vaccines, 20 Ave Fleming, B-1300 Wavre, Belgium
关键词
Chicken pox; GCC countries; Herpes zoster; Shingles; Varicella; Varicella zoster virus; HEALTH-CARE WORKERS; IMMUNIZATION PRACTICES; ADVISORY-COMMITTEE; UNITED-STATES; SAUDI-ARABIA; VACCINE; RECOMMENDATIONS; IMMUNITY; DISEASES; RUBELLA;
D O I
10.1007/s40121-022-00715-8
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction: The reactivation of varicella zoster virus (VZV) in previously infected individuals can cause herpes zoster (HZ), which is characterized by a localized, painful dermatomal rash. While there is a global trend of increasing HZ cases, there is a lack of research examining the epidemiology of HZ within the Gulf Cooperation Council (GCC) countries. Therefore, we aimed to critically appraise evidence on VZV and HZ epidemiology in the GCC countries and identify gaps in the current literature.Methods: A literature review was conducted via a comprehensive appraisal of the literature. PubMed and local-language journals were searched to identify articles related to HZ and VZV published up until 31 January 2022, with a sole focus on the GCC countries. Included studies reported on surveillance data, seroepidemiology, and patient outcomes for HZ and VZV, and comprised primary data reports, case series, case reports, narrative and systematic literature reviews, studies reporting HZ incidence or prevalence, and Ministry of Health reports.Results: Thirteen studies were found that reported on VZV seroprevalence in Saudi Arabia, the United Arab Emirates (UAE), and Qatar, ranging from 15.0% to 92.2%, while no data were identified for Bahrain, Kuwait, or Oman. There was very limited country-wide information on the incidence of HZ in GCC countries, and three identified studies reported HZ prevalence as seen in a single clinic, ranging from 0.62% to 2.3%. A single study from Saudi Arabia and government surveillance data reported on the impact of VZV vaccination on VZV infection, though there was no evidence on the impact of VZV vaccination on HZ.Conclusion: There is a clear gap in the literature regarding the incidence of HZ infection, and the impacts of HZ and VZV vaccinations in the GCC countries. Further research into the epidemiology of HZ is necessary to inform the implementation of vaccination programs in the GCC countries. [GRAPHICS] .
引用
收藏
页码:81 / 93
页数:13
相关论文
共 50 条
  • [31] Varicella zoster virus vaccines: potential complications and possible improvements
    Benjamin Silver
    Hua Zhu
    Virologica Sinica, 2014, (05) : 265 - 273
  • [32] Concurrent Varicella-Zoster Virus Reactivation and Recurrent Herpes Simplex Virus Infection in the C2 Dermatome With Varicella-Zoster Virus Encephalitis: A Case Report and Review of the Literature
    Hatlovic, Morgan A.
    Anzelc, Madison
    Franklin, Matthew
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)
  • [33] Incidence of serum antibody titers against varicella zoster virus in Japanese patients with herpes zoster
    Miyachi, Motoko
    Ihara, Honoka
    Imafuku, Shinichi
    JOURNAL OF DERMATOLOGY, 2017, 44 (06) : 656 - 659
  • [34] Identifying optimal vaccination scenarios to reduce varicella zoster virus transmission and reactivation
    Bakker, Kevin M.
    Eisenberg, Marisa C.
    Woods, Robert J.
    Martinez, Micaela E.
    BMC MEDICINE, 2022, 20 (01)
  • [35] Herpes simplex virus and varicella zoster virus: recent advances in therapy
    De, Surjo K.
    Hart, Jennifer C. L.
    Breuer, Judith
    CURRENT OPINION IN INFECTIOUS DISEASES, 2015, 28 (06) : 589 - 595
  • [36] Rapid contamination of the environments with varicella-zoster virus DNA from a patient with herpes zoster
    Yoshikawa, T
    Ihira, M
    Sazuki, K
    Suga, S
    Tomitaka, A
    Ueda, H
    Asano, Y
    JOURNAL OF MEDICAL VIROLOGY, 2001, 63 (01) : 64 - 66
  • [38] Swiss recommendations for the management of varicella zoster virus infections
    Kempf, W.
    Meylan, P.
    Gerber, S.
    Aebi, C.
    Agosti, R.
    Buechner, S.
    Coradig, B.
    Garweg, J.
    Hirsch, H. H.
    Kind, C.
    Lauper, U.
    Lautenschlager, S.
    Reusser, R.
    Ruef, C.
    Wunderli, W.
    Nadal, D.
    SWISS MEDICAL WEEKLY, 2007, 137 (17-18) : 239 - 251
  • [39] The Biology of Varicella-Zoster Virus Replication in the Skin
    Tommasi, Cristina
    Breuer, Judith
    VIRUSES-BASEL, 2022, 14 (05):
  • [40] Vaccines against varicella-zoster virus (VZV)
    Salleras, Luis
    Salleras, Montserrat
    Soldevila, Nuria
    Prat, Andreu
    Garrido, Patricio
    Dominguez, Angela
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2015, 33 (06): : 411 - 423